Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Senate Finance Dives Deeper Into PBM Weeds, Including Brand Over Generic Preferences
Jul 17 2023
•
By
Sarah Karlin-Smith
The Senate Finance Committee wants PBM justification of brand vs. generic, biosimilar tiering preferences. • Source: Shutterstock
More from Legislation
More from Pink Sheet